On Friday, Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) was 10.94% up from the session before settling in for the closing price of $1.28. A 52-week range for RVPH has been $0.60 – $6.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 40.40%. With a float of $28.44 million, this company’s outstanding shares have now reached $33.44 million.
Let’s determine the extent of company efficiency that accounts for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Reviva Pharmaceuticals Holdings Inc. (RVPH) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Reviva Pharmaceuticals Holdings Inc. stocks. The insider ownership of Reviva Pharmaceuticals Holdings Inc. is 14.94%, while institutional ownership is 21.83%.
Reviva Pharmaceuticals Holdings Inc. (RVPH) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.44 earnings per share (EPS) during the time that was less than consensus figure (set at -0.37) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.40% per share during the next fiscal year.
Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) Trading Performance Indicators
You can see what Reviva Pharmaceuticals Holdings Inc. (RVPH) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.30, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.85 in one year’s time.
Technical Analysis of Reviva Pharmaceuticals Holdings Inc. (RVPH)
Looking closely at Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH), its last 5-days average volume was 0.33 million, which is a drop from its year-to-date volume of 0.35 million. As of the previous 9 days, the stock’s Stochastic %D was 87.88%. Additionally, its Average True Range was 0.13.
During the past 100 days, Reviva Pharmaceuticals Holdings Inc.’s (RVPH) raw stochastic average was set at 84.54%, which indicates a significant increase from 84.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.31% in the past 14 days, which was lower than the 119.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1478, while its 200-day Moving Average is $2.3138. However, in the short run, Reviva Pharmaceuticals Holdings Inc.’s stock first resistance to watch stands at $1.5266. Second resistance stands at $1.6332. The third major resistance level sits at $1.7765. If the price goes on to break the first support level at $1.2767, it is likely to go to the next support level at $1.1334. Should the price break the second support level, the third support level stands at $1.0268.
Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) Key Stats
There are 27,919K outstanding shares of the company, which has a market capitalization of 47.48 million. As of now, sales total 0 K while income totals -39,260 K. Its latest quarter income was 0 K while its last quarter net income were -7,860 K.
